Idarubicin hydrochloride 25MG and 4 more items

State & local contract award Virginia Awarded

Contract number
A207_PO-0453491-V3
Awardee
FISHER SCIENTIFIC COMPANY LLC
Contracting organization
University of Virginia
Cumulative value
$643.94

About this award

Fisher Scientific Company LLC received a contract award from the University of Virginia on September 26, 2026, for the supply of pharmaceutical products. The contract, designated A207_PO-0453491-V3, carries a cumulative value of $643. The contracting organization is located in Virginia.

The contract encompasses five distinct pharmaceutical line items totaling 641 units. The products include Idarubicin Hydrochloride 25mg (166 units), Roxadustat 50mg (139 units), Risperidone 500mg (72 units), Rapamycin 200mg (134 units), and Midostaurin 10mg (130 units). Each line item is priced at $1 per unit, with delivery directed to the buyer. These pharmaceutical products span multiple therapeutic categories, including oncology, nephrology, psychiatry, immunosuppression, and hematologic malignancy treatment applications.

Line items

Item Total
Idarubicin hydrochloride 25MG 166 Each × $1.00 $166.00
Roxadustat 50 MG 139 Each × $1.00 $139.00
Risperidone 500MG 72 Each × $1.00 $72.00
Rapamycin 200MG 134 Each × $1.00 $134.00
Midostaurin 10MG 130 Each × $1.00 $130.00

Award details come from logi.cgieva.com. Updated .

Quick answers

Who was awarded contract A207_PO-0453491-V3?

Contract A207_PO-0453491-V3 was awarded to FISHER SCIENTIFIC COMPANY LLC by University of Virginia on September 26, 2026.

How much is contract A207_PO-0453491-V3 worth?

Its cumulative value is $643.94.

On GovTribe

See this award's full record

  • Every line item and file
  • The contract it was ordered under and its other orders
  • Similar state and local awards and opportunities
  • Ask GovTribe AI about this award